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http://www.wjso.com/content/10/1/59CASE REPORT Open AccessIntraduodenal sarcoma recurrence of
retroperitoneal origin: an unusual cause for a
duodenal obstruction
Jean J Bao1, John C Mansour1, Robert D Timmerman2, Amanda Kirane1, Gene E Ewing3 and Roderich E Schwarz1*Abstract
Soft tissue sarcomas are uncommon tumors, and intraduodenal soft tissue sarcoma manifestation is even more rare.
Only three cases of intraduodenal sarcomas have been reported in the literature thus far. Here, we report a case of
an intraduodenal recurrence of a retroperitoneal sarcoma causing bowel obstruction. This unusual recurrence
pattern likely relates to the patient’s previous resection and radiation treatment, and highlights the benefits,
limitations and follow-up strategies after multimodality treatment.
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Soft tissue sarcomas (STS) are rare tumors, accounting
for less than 1% of all newly diagnosed malignancies [1].
Of all STS, only 20% originate from retroperitoneal and
intra-abdominal locations [2]. These tumors are commonly
extensive and locally invasive, rendering complete surgical
resection challenging. Nonetheless, resection remains the
mainstay of therapy for retroperitoneal and intra-abdominal
STS, because radiotherapy is limited due to incomplete
responses and potential toxicity to adjacent structures, and
because highly effective adjuvant chemotherapy remains to
be identified. To the best of our knowledge, there are only
three cases of intraduodenal STS reported in the literature,
two of which are recurrent retroperitoneal STS and one
being synchronous with the retroperitoneal sarcoma [3-5].
We report a case of an intraduodenal recurrence of a retro-
peritoneal sarcoma causing bowel obstruction.Case presentation
A 60-year-old male patient had previously under-
gone a radical resection of a T2bN0M0G3 Stage III
retroperitoneal sarcoma, including right nephrectomy
and cholecystectomy, in 2002. Pathologic evaluation
demonstrated a 25 cm high-grade liposarcoma with* Correspondence: Roderich.Schwarz@utsouthwestern.edu
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reproduction in any medium, provided the ordifferent histologic components, including myxoid,
round cell, well-differentiated, sclerosing and pleo-
morphic patterns. Surgical margins were negative as
the tumor did not invade the kidney, and since the
renal vein and ureter were free of tumor as well.
The patient did not undergo any additional therapy. Sur-
veillance magnetic resonance imaging in 2007 revealed an
isolated tumor recurrence in the retroperitoneum. An ex-
ploratory celiotomy revealed tumor involvement of the
duodenum, head of the pancreas, superior mesenteric
vein, vena cava and left renal vein with severe adhesive
changes, leading to the intraoperative assessment of unre-
sectable disease. Subsequently, the patient underwent
stereotactic body radiation to the retroperitoneal tumor in
five fractions for a total dose of 30 Gy, without complica-
tion. Postradiation imaging revealed near complete reso-
lution of the retroperitoneal mass.
One year later, the patient presented with weight loss,
postprandial abdominal pain, nausea and vomiting. Cross-
sectional imaging revealed a 7 cm mass with involvement
of the third portion of the duodenum (Figure 1). However,
there was no obvious involvement of the pancreatic head or
the other structures that were noted to be involved during
the previous laparotomy. We elected to perform another
resection attempt, including a possible pancreatoduode-
nectomy or retroperitoneal vascular resection if necessary.
At exploration, the residual tumor was an entirely intra-
duodenal, pedunculated mass at the posterior duodenal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Recurrent tumor and relationship to the duodenum (left and center image) and large vessels (right image), as indicated by
the arrows.
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lumen. The patient underwent a duodenotomy and stalk
transection of the polypoid mass, followed by partial
duodenal resection with hand-sewn duodenojejunal
anastomosis (Figure 2). Surgical pathology examination
revealed a 9.5 cm recurrent high-grade liposarcoma with
polypoid intraluminal growth containing myxoid, round
cell, well-differentiated, sclerosing and focally pleo-
morphic areas. Surgical margins were negative as the
tumor came within 0.1 cm of the stalk margin and there
was no evidence of additional neoplastic components
within the remaining resected duodenum. The post-
operative course was uncomplicated, and the patient has
demonstrated no recurrence up to 30 months from this
resection.Figure 2 Intraoperative images of an entirely intraduodenal tumor reDiscussion
Intraduodenal presentation of STS is rare. To the best of
our knowledge, there are only three cases reported in the
literature. In the patient described, duodenal involvement
by the extraduodenal sarcoma may have developed from
either contiguous extension or hematogenous metastasis.
However, at the time of the duodenectomy, there was no
evidence of any extraduodenal disease or any distant me-
tastasis. The solely intraduodenal growth pattern suggests
that the previous radiation therapy to the retroperitoneal
area, with duodenal shielding, had an impact in generating
such an unusual disease pattern. This duodenal shielding
from radiation together with a complete extraduodenal re-
sponse to radiation therapy may thus have facilitated the
isolated intraduodenal recurrence.sected with primary duodenojejunal repair.
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of retroperitoneal sarcomas, with a higher local recur-
rence rate than non-liposarcomas (58% versus 22%) [6].
Even when tumor grade is taken into account, failure of
disease control is mostly due to locoregional recurrence.
For liposarcomas with greater potential for positive mar-
gin resections or higher risk for recurrence, preoperative
radiotherapy should be considered. Radiation therapy is
frequently used as an adjunct to operative therapy in the
treatment of retroperitoneal sarcomas, administered at a
dose of 40 to 50 Gy. Tumors with a significant myxoid
component are more likely to demonstrate a size reduc-
tion when treated with external beam radiation [7].
Higher doses can be associated with significant gastro-
intestinal toxicity, which is the reason for contouring of
the radiation field to spare those structures most suscep-
tible to radiation-induced injury, such as the duodenum
[8]. Our patient received a dose of 30 Gy in five fractions
which effectively controlled the extraduodenal disease.
The dose to the duodenum was reduced by intensity
modulation. As the planning target volume overlapped
portions of the circumference of the duodenum, the
adjacent duodenal wall was included in the high dose vol-
ume. An avoidance structure was contoured for planning
consisting of the non-adjacent wall of the duodenum out-
side of the planning target volume. Strict avoidance criteria
were placed on this structure allowing steep dose falloff gra-
dients specifically in the direction of the duodenum. This
specific intentional shielding of the duodenum is likely the
factor responsible for the development of this unusual
pattern of recurrence.
The patient was symptomatic from the duodenal recur-
rence with partial bowel obstruction and weight loss.
Given his excellent performance status and the lack of vas-
cular involvement by the tumor, the decision was made to
resect the lesion. Not resecting the tumor would almost
certainly have guaranteed tumor progression and, ultim-
ately, oncologic failure with a high risk for death from the
disease. Radiation was not considered as part of the therapy
for the duodenal recurrence as there was clear evidence of
bowel involvement. Performing radiation therapy on the
bowel for a malignant obstructive process would likely lead
to significant gastrointestinal toxicity, with questionable
outcomes regarding the resolution of the obstructive
component.Conclusions
Complex retroperitoneal STS often mandate a multidis-
ciplinary approach to treatment sequencing and selection.
An awareness of sarcoma subtype-specific responses to ra-
diation may help select patients who are more likely to
demonstrate extraordinary responses. For patients with
initially unresectable tumors and good response toradiation therapy, resection options should be re-evaluated
as they can lead to lasting disease or symptom control.
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